Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE): epidemiology, emerging organisms, and economics

BMC Pediatrics

Otto G. Vanderkooi^2,20  Raymond Tellier⁵  Phillip Tarr^1,18  James Talbot¹  Lawrence W. Svenson^1,10  Shannon MacDonald^1,16  Judy MacDonald^1,17  Martin Lavoie¹  James Kellner³  David W. Johnson^1,15  Xi Jiang^1,12  Tim Graham^1,11  Mohamed Eltorki⁷  Steven J. Drews^2,21  James Dickinson⁸  Gillian R. Currie^1,13  Linda Chui²  Andy Chuck^1,19  Samina Ali⁶  Xiao-Li Pang^2,21  Marie Louie⁴  Bonita E. Lee^1,14  Stephen B. Freedman⁹ 

[1] Alberta Health, University of Alberta, Edmonton, AB, Canada;University of Alberta, Edmonton, AB, Canada;Department of Pediatrics, Section of Infectious Diseases, Alberta Children’s Hospital, Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada;Provincial Laboratory for Public Health (ProvLab, Alberta Health Services), Departments of Microbiology, Immunology & Infectious Disease and Pathology & Laboratory Medicine, University of Calgary, Calgary, AB, Canada;Department of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, AB, Canada;Department of Pediatrics & Emergency Medicine, University of Alberta, Faculty of Medicine & Dentistry, Women and Children’s Health Research Institute, Stollery Children’s Hospital, Edmonton, AB, Canada;Department of Pediatrics, Section of Pediatric Emergency Medicine, Alberta Children’s Hospital, University of Calgary, Calgary, AB, Canada;Departments of Family Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada;Department of Pediatrics, Sections of Pediatric Emergency Medicine and Gastroenterology, Alberta Children’s Hospital, Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada;Alberta Health Services, University of Calgary, Calgary, AB, Canada;Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada;Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA;Department of Community Health Sciences, Alberta Children’s Hospital Research Institute, O’Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada;Department of Pediatrics, Stollery Children’s Hospital, University of Alberta, Edmonton, AB, Canada;Departments of Pediatrics and Physiology and Pharmacology, Section of Pediatric Emergency Medicine, Alberta Children’s Hospital, Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada;Faculty of Nursing, University of Alberta, Edmonton, AB, Canada;Alberta Health Services, Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada;Division of Gastroenterology, Washington University, St. Louis, MO, USA;Institute of Health Economics, Edmonton, AB, Canada;Department of Microbiology, Immunology & Infectious Diseases, Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada;Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, Canada

关键词: Vaccine;    Economic analysis;    Discrete choice experiments;    Rectal swabs;    Polymerase Chain reaction;    Rotavirus;    Norovirus;    Gastroenteritis;    Diarrhea;    Vomiting;   

Others  :  1221506
DOI  :  10.1186/s12887-015-0407-7

 received in 2015-04-08, accepted in 2015-07-15,  发布年份 2015

【 摘 要 】

Background

Each year in Canada there are 5 million episodes of acute gastroenteritis (AGE) with up to 70 % attributed to an unidentified pathogen. Moreover, 90 % of individuals with AGE do not seek care when ill, thus, burden of disease estimates are limited by under-diagnosing and under-reporting. Further, little is known about the pathogens causing AGE as the majority of episodes are attributed to an “unidentified” etiology. Our team has two main objectives: 1) to improve health through enhanced enteric pathogen identification; 2) to develop economic models incorporating pathogen burden and societal preferences to inform enteric vaccine decision making.

Methods/Design

This project involves multiple stages: 1) Molecular microbiology experts will participate in a modified Delphi process designed to define criteria to aid in interpreting positive molecular enteric pathogen test results. 2) Clinical data and specimens will be collected from children aged 0–18 years, with vomiting and/or diarrhea who seek medical care in emergency departments, primary care clinics and from those who contact a provincial medical advice line but who do not seek care. Samples to be collected will include stool, rectal swabs (N = 2), and an oral swab. Specimens will be tested employing 1) stool culture; 2) in-house multiplex (N = 5) viral polymerase chain reaction (PCR) panel; and 3) multi-target (N = 15) PCR commercially available array. All participants will have follow-up data collected 14 days later to enable calculation of a Modified Vesikari Scale score and a Burden of Disease Index. Specimens will also be collected from asymptomatic children during their well child vaccination visits to a provincial public health clinic. Following the completion of the initial phases, discrete choice experiments will be conducted to enable a better understanding of societal preferences for diagnostic testing and vaccine policy. All of the results obtained will be integrated into economic models.

Discussion

This study is collecting novel samples (e.g., oral swabs) from previously untested groups of children (e.g., those not seeking medical care) which are then undergoing extensive molecular testing to shed a new perspective on the epidemiology of AGE. The knowledge gained will provide the broadest understanding of the epidemiology of vomiting and diarrhea of children to date.

【 授权许可】

   
2015 Freedman et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Ivaska L, Niemela J, Heikkinen T, Vuorinen T, Peltola V. Identification of respiratory viruses with a novel point-of-care multianalyte antigen detection test in children with acute respiratory tract infection. J Clin Virol. 2013; 57(2):136-40.
• [2]Manage DP, Lauzon J, Atrazhev A, Pang X, Pilarski LM. A novel method for sample delivery and testing of whole blood: gel strip PCR for point of care (POC) molecular diagnostics. Lab Chip. 2013; 13(20):4011-4.
• [3]Kaigala GV, Huskins RJ, Preiksaitis J, Pang XL, Pilarski LM, Backhouse CJ. Automated screening using microfluidic chip-based PCR and product detection to assess risk of BK virus-associated nephropathy in renal transplant recipients. Electrophoresis. 2006; 27(19):3753-63.
• [4]Government of Alberta. Alberta’s Health Research and Innovation Strategy; Available at: http://eae.alberta.ca/media/277640/ahris_report_aug2010_web.pdf; Accessed October 25, 2013. In.; Published August 2010.
• [5]Alberta Innovates Health Solutions. SCN/OCN Research Connections; Available at: http://www.aihealthsolutions.ca/media/FINAL-Report.pdf; Accessed July 23, 2015. In.; Published July 2013.
• [6]Majowicz SE, McNab WB, Sockett P, Henson TS, Dore K, Edge VL, Buffett MC, Fazil A, Read S, McEwen S et al.. Burden and cost of gastroenteritis in a Canadian community. J Food Prot. 2006; 69(3):651-9.
• [7]Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL et al.. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004–2005. Emerg Infect Dis. 2011; 17:1381-8.
• [8]Freedman SB, Gouin S, Bhatt M, Black KJ, Johnson D, Guimont C, Joubert G, Porter R, Doan Q, van Wylick R et al.. Prospective assessment of practice pattern variations in the treatment of pediatric gastroenteritis. Pediatrics. 2011; 127(2):e287-95.
• [9]Church DL, Cadrain G, Kabani A, Jadavji T, Trevenen C. Practice guidelines for ordering stool cultures in a pediatric population. Alberta Children’s Hospital, Calgary, Alberta, Canada. Am J Clin Pathol. 1995; 103(2):149-53.
• [10]Scott S: Results of the TREKK Needs Assessment. In: TREKK Network Meeting, October 5, 2013, Winnipeg, MB: 2013; 2013. http://trekk.ca/teams/phase-1-needsassessment. Accessed July 23, 2015
• [11]Butler-Jones D. The Chief Public Health Officer’s Report on the State of Public Health in Canada - 2013: Infectious Disease - The Never-ending Threat. Avialable at: http://www.phac-aspc.gc.ca/cphorsphc-respcacsp/2013/assets/pdf/2013-eng.pdf; Accessed November 26, 2013. In. Edited by Canada PHAo.
• [12]Government of Alberta (Alberta Health and Wellness). Escherishia coli verotoxigenic infections. Published March 2011. Available at: http://www.health.alberta.ca/documents/Guidelines-Escherichia-coli-Verotoxigenic-2011.pdf. Accessed December 2, 2013. In.
• [13]Proulx F, Sockett P. Prospective surveillance of Canadian children with the haemolytic uraemic syndrome. Pediatr Nephrol. 2005; 20(6):786-90.
• [14]Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008; 23(10):1749-60.
• [15]Tariq L, Haagsma J, Havelaar A. Cost of illness and disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. J Food Prot. 2011; 74(4):545-52.
• [16]Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet. 1998; 352(9135):1207-12.
• [17]Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, Peterson JM, Butani L, Jones DP, Havens PL et al.. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med. 2011; 165(10):884-9.
• [18]Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol. 2012; 27(8):1407-10.
• [19]Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics. 2005; 115(6):e673-80.
• [20]Hall AJ, Lopman BA, Payne DC, Patel MM, Gastanaduy PA, Vinje J, Parashar UD. Norovirus disease in the United States. Emerg Infect Dis. 2013; 19(8):1198-205.
• [21]Chen Z, Sosnovtsev SV, Bok K, Parra GI, Makiya M, Agulto L, Green KY, Purcell RH. Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol. 2013; 87(17):9547-57.
• [22]Busani L, Boccia D, Caprioli A, M Ruggeri F, Morabito S, Minelli F, Lana S, Rizzoni G, Giofre F, Mazzeo M. Public health implications of a case of haemolytic-uraemic syndrome associated with a concomitant outbreak of mild gastroenteritis in a small rural community. Epidemiol Infect. 2006; 134(2):407-13.
• [23]Pang XL, Lee BE, Pabbaraju K, Gabos S, Craik S, Payment P, Neumann N. Pre-analytical and analytical procedures for the detection of enteric viruses and enterovirus in water samples. J Virol Methods. 2012; 184(1–2):77-83.
• [24]Wikswo ME, Desai R, Edwards KM, Staat MA, Szilagyi PG, Weinberg GA, Curns AT, Lopman B, Vinje J, Parashar UD et al.. Clinical profile of children with norovirus disease in rotavirus vaccine era. Emerg Infect Dis. 2013; 19(10):1691-3.
• [25]Richards GP. Critical review of norovirus surrogates in food safety research: rationale for considering volunteer studies. Food Environ Virol. 2012; 4(1):6-13.
• [26]Coyle C, Coyle K, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW, Le Saux N. Cost effectiveness of infant vaccination for rotavirus in Canada. Can J Infect Dis Med Microbiol. 2012; 23(2):71-7.
• [27]Fisman DN, Chan CH, Lowcock E, Naus M, Lee V. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation. Vaccine. 2012; 30(52):7601-7.
• [28]Aballea S, Millier A, Quilici S, Caroll S, Petrou S, Toumi M. A critical literature review of health economic evaluations of rotavirus vaccination. Hum Vaccin Immunother. 2013; 9(6):1272-88.
• [29]Pang XL, Preiksaitis JK, Lee BE. Enhanced enteric virus detection in sporadic gastroenteritis using a multi-target real-time PCR panel – One-year study. J Medical Virology (in press) 2013.
• [30]Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med. 2000; 154(6):578-85.
• [31]Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW. Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005–2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J. 2010; 29(9):879-82.
• [32]Lee BE, Pang XL. New strains of norovirus and the mystery of viral gastroenteritis epidemics. CMAJ. 2013; 185(16):1381-2.
• [33]Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep. 2011; 60(RR-3):1-18.
• [34]Havelaar AH, Haagsma JA, Mangen MJ, Kemmeren JM, Verhoef LP, Vijgen SM, Wilson M, Friesema IH, Kortbeek LM, van Duynhoven YT et al.. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol. 2012; 156(3):231-8.
• [35]Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT et al.. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013; 368(12):1121-30.
• [36]Vaillant V, de Valk H, Baron E, Ancelle T, Colin P, Delmas MC, Dufour B, Pouillot R, Le Strat Y, Weinbreck P et al.. Foodborne infections in France. Foodborne Pathog Dis. 2005; 2(3):221-32.
• [37]Hall G, Kirk MD, Becker N, Gregory JE, Unicomb L, Millard G, Stafford R, Lalor K. Estimating foodborne gastroenteritis, Australia. Emerg Infect Dis. 2005; 11(8):1257-64.
• [38]Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis. 2011; 17(1):7-15.
• [39]Adlerberth I, Huang H, Lindberg E, Aberg N, Hesselmar B, Saalman R, Nord CE, Wold AE, Weintraub A. Toxin-producing Clostridium difficile strains as long-term gut colonizers of healthy infants. J Clin Microbiol. 2013; 52:173.
• [40]Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003; 326(7393):816-9.
• [41]Lee BE, Robinson JL, Khurana V, Pang XL, Preiksaitis JK, Fox JD. Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests. J Med Virol. 2006; 78(5):702-10.
• [42]Pang XL, Jiang J. Gastroenteritis Viruses. 10th Manual of Clinical Microbiology. Versalovic J, editor. American Society for Microbiology, Washington, DC; 2011.
• [43]Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr. 2008; 46 Suppl 2:S81-122.
• [44]Denno DM, Stapp JR, Boster DR, Qin X, Clausen CR, Del Beccaro KH, Swerdlow DL, Braden CR, Tarr PI. Etiology of diarrhea in pediatric outpatient settings. Pediatr Infect Dis J. 2005; 24(2):142-8.
• [45]Majowicz SE, Edge VL, Fazil A, McNab WB, Dore KA, Sockett PN, Flint JA, Middleton D, McEwen SA, Wilson JB. Estimating the under-reporting rate for infectious gastrointestinal illness in Ontario. Can J Public Health. 2005; 96(3):178-81.
• [46]Freedman SB, Eltorky M, Gorelick M. Evaluation of a gastroenteritis severity score for use in outpatient settings. Pediatrics. 2010; 125(6):e1278-85.
• [47]Schnadower D, Tarr PI, Gorelick MH, O’Connell K, Roskind CG, Powell EC, Rao J, Bhatt S, Freedman SB. Validation of the Modified Vesikari Score in Children with Gastroenteritis in 5 U.S. Emergency Departments. J Pediatr Gastroenterol Nutr. 2013; 57:514.
• [48]Luinstra K, Goldfarb D, Castriciano S, Chong S, Mahony J, Smieja M. Stability of nucleic acid recovery from flocked rectal swabs after prolonged storage at elevated temperatures. Clinical Virology Symposium, Daytona Beach FL; 2013.
• [49]Goldfarb D, Steenhoff A, Pernica J, Castriciano S, Chong S, Luinstra K, Morris G, Mokomane M, Goercke I, Mahony J et al.. Copan flocked rectal swab samples outperform bulk stool for the detection of diarrheal pathogens in children when using the xTAG gastrointestinal pathogen panel (GPP) assay. Clinical Virology Symposium, Daytona Beach FL; 2013.
• [50]Claas EC, Burnham CA, Mazzulli T, Templeton K, Topin F. Performance of the xTAG(R) gastrointestinal pathogen panel, a multiplex molecular assay for simultaneous detection of bacterial, viral, and parasitic causes of infectious gastroenteritis. J Microbiol Biotechnol. 2013; 23(7):1041-5.
• [51]Navidad JF, Griswold DJ, Gradus MS, Bhattacharyya S. Evaluation of Luminex xTAG gastrointestinal pathogen analyte-specific reagents for high-throughput, simultaneous detection of bacteria, viruses, and parasites of clinical and public health importance. J Clin Microbiol. 2013; 51(9):3018-24.
• [52]Hasing ME, Lee BE, Preiksaitis JK, Tellier R, Honish L, Senthilselvan A, Pang XL. Emergence of a New Norovirus GII.4 Variant and Changes in the Historical Biennial Pattern of Norovirus Outbreak Activity in Alberta, Canada (2008–2012). J Clin Microbiol. 2013; 51:2204.
• [53]Iturriza Gomara M, Kang G, Mammen A, Jana AK, Abraham M, Desselberger U, Brown D, Gray J. Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol. 2004; 42(6):2541-7.
• [54]Sarantis H, Johnson G, Brown M, Petric M, Tellier R. Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. J Clin Microbiol. 2004; 42(9):3963-9.
• [55]PulseNet International. Molecular typing by PFGE. Available at: http://www.pulsenetinternational.org/protocols/. Accessed July 23, 2015.
• [56]Manage DP, Lauzon J, Atrazev A, Chavali R, Samuel RA, Chan B, Morrissey YC, Gordy W, Edwards AL, Larison K et al.. An enclosed in-gel PCR amplification cassette with multi-target, multi-sample detection for platform molecular diagnostics. Lab Chip. 2013; 13(13):2576-84.
• [57]Bhutta ZA, Zipursky A, Wazny K, Levine MM, Black RE, Bassani DG, Shantosham M, Freedman SB, Grange A, Kosek M et al.. Setting priorities for development of emerging interventions against childhood diarrhoea. J Glob Health. 2013; 3(1):10302.